Page 1 of Clinical Trials for Insys Therapeutics Inc [SPONSOR-COLLABORATORS], 24 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer
Last Updated: June 2, 2011
Condition(s): Prostate Cancer
2
Completed
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer
Last Updated: June 30, 2011
Condition(s): Neoplasm
3
Completed
IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
Last Updated: June 30, 2011
Condition(s): Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma
4
Active, not recruiting
Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer
Last Updated: April 12, 2011
Condition(s): Pancreatic Cancer
5
Withdrawn
Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
Last Updated: June 30, 2011
Condition(s): Recurrent Malignant Glioma
6
Completed
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
Last Updated: June 30, 2011
Condition(s): Neoplasm
7
Completed
Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer
Last Updated: June 30, 2011
Condition(s): Neoplasms
8
Completed
Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies
Last Updated: April 12, 2011
Condition(s): Neoplasms
9
Completed
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Last Updated: June 2, 2011
Condition(s): Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Mixed Oligoastrocytoma; Malignant Astrocytoma
10
Completed
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
Last Updated: April 12, 2011
Condition(s): Neoplasms
11
Completed
Long Term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain
Last Updated: March 23, 2012
Condition(s): Cancer; Pain
12
Completed
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
Last Updated: June 2, 2011
Condition(s): Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Mixed Oligoastrocytoma
13
Completed
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer
Last Updated: June 30, 2011
Condition(s): Neoplasms
14
Completed
Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions
Last Updated: March 23, 2012
Condition(s): Bioavailability
15
Terminated
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
Last Updated: April 12, 2011
Condition(s): Neoplasms
16
Completed
Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
Last Updated: June 2, 2011
Condition(s): Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Mixed Oligoastrocytoma
17
Active, not recruiting
Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer
Last Updated: June 9, 2011
Condition(s): Breast Cancer
18
Completed
Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors
Last Updated: June 30, 2011
Condition(s): Solid Tumors
19
Completed
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
Last Updated: June 2, 2011
Condition(s): Glioblastoma Multiforme
20
Terminated
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses
Last Updated: April 12, 2011
Condition(s): Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Insys+Therapeutics+Inc

Page 1 of Clinical Trials for Insys Therapeutics Inc [SPONSOR-COLLABORATORS], 24 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About